10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0001564590-18-026844`
Period End Date	20180930
Filing Date	20181105
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	nbix-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 68 Cash Flow Statement 60

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$254.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$195.73M	USD	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$261.22M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$439.61M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$54.10M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$31.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Inventory	`InventoryNet`	$1.02M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Inventory	`InventoryNet`	$6.05M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.79M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$18.90M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	90.67M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$6.84M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$554.92M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	90.67M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$714.39M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.79M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.81M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.62M	USD	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$185.26M	USD	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$247.36M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.50M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.48M	USD	Point-in-time
Total assets	`Assets`	$933.75M	USD	Point-in-time
Total assets	`Assets`	$817.59M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$53.52M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$72.02M	USD	Point-in-time
Current portion of convertible senior notes	`ConvertibleDebtCurrent`	-	USD	Point-in-time
Current portion of convertible senior notes	`ConvertibleDebtCurrent`	$383.65M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$731.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$906.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$54.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$456.40M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.50M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$8.04M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$3.13M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$12.11M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$369.62M	USD	Point-in-time
Total liabilities	`Liabilities`	$445.45M	USD	Point-in-time
Total liabilities	`Liabilities`	$486.23M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 90,673,214 as of September 30, 2018 and 88,793,903 as of December 31, 2017	`CommonStockValue`	$89.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 90,673,214 as of September 30, 2018 and 88,793,903 as of December 31, 2017	`CommonStockValue`	$91.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.57B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.65B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.06M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.20B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.20B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$372.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$447.51M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$817.59M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$933.75M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$319.75M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$151.76M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$67.11M	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$60.77M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$3.35M	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$494.00K	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.55M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$433.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$96.21M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$35.48M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$121.42M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$22.46M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$60.40M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$113.60M	USD	3 Qtrs
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$43.87M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$179.95M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$304.72M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$97.43M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$66.77M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$210.30M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-143.19M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$15.02M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$54.32M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-6.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.67M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.34M	USD	1 Quarter
Interest expense	`InterestExpense`	$22.77M	USD	3 Qtrs
Interest expense	`InterestExpense`	$12.10M	USD	3 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$5.86M	USD	3 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$10.78M	USD	3 Qtrs
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$4.11M	USD	1 Quarter
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$2.21M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-3.56M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-11.99M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-5.13M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-6.24M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.03M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-149.44M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-1.70	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.03	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.52	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-1.70	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.03	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	87.89M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.06M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	88.33M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.56M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.80M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.33M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.27M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.89M	shares	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.03M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-149.44M	USD	3 Qtrs
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-216.00K	USD	3 Qtrs
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$179.00K	USD	1 Quarter
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$753.00K	USD	1 Quarter
Net unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-206.00K	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-149.65M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$2.83M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-10.95M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$51.52M	USD	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$3.03M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-11.12M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-149.44M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.75M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.69M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$6.75M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$13.04M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$989.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$526.00K	USD	3 Qtrs
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.44M	USD	3 Qtrs
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.20M	USD	3 Qtrs
Non-cash share-based compensation expense	`ShareBasedCompensation`	$29.07M	USD	3 Qtrs
Non-cash share-based compensation expense	`ShareBasedCompensation`	$44.80M	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-1.26M	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-482.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$22.97M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$29.82M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.91M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$242.00K	USD	3 Qtrs
Reimbursements for tenant improvements	`IncreaseDecreaseInReimbursementsOfTenantImprovements`	-	USD	3 Qtrs
Reimbursements for tenant improvements	`IncreaseDecreaseInReimbursementsOfTenantImprovements`	$3.66M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$4.32M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$6.84M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$11.11M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$15.58M	USD	3 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$-175.00K	USD	3 Qtrs
Other current liabilities	`IncreaseDecreaseInOtherCurrentLiabilities`	$-188.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$50.91M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-134.91M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$329.29M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$444.54M	USD	3 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$211.40M	USD	3 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$257.24M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.56M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.80M	USD	3 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00K	USD	3 Qtrs
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$30.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-191.86M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-136.66M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$8.27M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$27.75M	USD	3 Qtrs
Proceeds from issuance of convertible senior notes, net	`ProceedsFromConvertibleDebt`	$502.78M	USD	3 Qtrs
Proceeds from issuance of convertible senior notes, net	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$511.05M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.75M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$184.28M	USD	3 Qtrs
Net (decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-58.00M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.43M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$272.43M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.82M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	3 Qtrs
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$1.80M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.